<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-62112</identifier>
<setSpec>0556-6177</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">No disponible</dc:title>
<dc:description xml:lang="en">Background and objectives: Thyrotropin-receptor antibodies are characteristicof patients with Graves´ disease. They are not detected inthe healthy general population, but their presence has been communicatedin other autoimmune thyroid diseases. The objective of this workconsists of researching, by means of a commercially available test, theprevalence of these antibodies in patients with autoimmune spontaneoushypothyroidism.Patients and methods: We conducted a cross-sectional study in adultoutpatients without acute illness, with primary or subclinical hypothyroidism,with or without goiter, and without thyroid associated ophthalmopathy,who had been referred to an Endocrinology clinic. Determinationsof free thyroxine, thyrotropin, thyroid peroxidase antibodies and thyrotropin-receptor antibodies were carried out. The calculated sample size was45 individuals, for a given prevalence of thyrotropin-receptor antibodiesof 3%, a confi dence level of 95% and a precision level of 5%.Results: Men accounted for 15.6% of the patients, 20% of the wholegroup had goiter, 24.4% had primary hypothyroidism, and the presenceof peroxidase thyroid antibodies was demonstrated in 73.3% of the subjects.A statistically signifi cant relationship was not found between theselast two properties. Thyrotropin-receptor antibodies were detectable in2 patients (4.4%), but positive in none.Conclusions: The hypothyroid patients referred to an Endocrinology clinicwere found to have zero prevalence of serum thyrotropin-receptor antibodies.It is, therefore, unnecessary to determine these antibodies in thistype of patients. On the other hand, the fi nding of positive thyrotropinreceptorantibodies in serum is specifi c for Graves´ disease, which canbe diagnosed on this basis whatever the patient&#146;s thyroid function(AU)</dc:description>
<dc:creator>Ronzón, A</dc:creator>
<dc:creator>Botas, P</dc:creator>
<dc:creator>Maciá, C</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Fundamento y objetivos: los anticuerpos anti-receptor de tirotropina soncaracterísticos de la enfermedad de Graves-Basedow. En la poblacióngeneral sana no se detectan, pero se ha comunicado su presencia enotras enfermedades tiroideas autoinmunitarias. El objetivo de este trabajoconsiste en investigar, mediante un ensayo de uso clínico, la prevalenciade detectabilidad y positividad de estos anticuerpos en pacientes conhipotiroidismo autoinmunitario espontáneo.Pacientes y métodos: se llevó a cabo un estudio transversal en adultos nohospitalizados, y sin enfermedad aguda, con hipotiroidismo, subclínicoo franco, con o sin bocio, y sin oftalmopatía tiroidea, que acudieron auna consulta externa de Endocrinología. Se realizaron determinacionesde tiroxina libre, tirotropina, anticuerpos anti-peroxidasa tiroidea y anticuerposanti-receptor de tirotropina. El tamaño muestral calculado, parauna proporción esperada de detectabilidad de anticuerpos anti-receptorde tirotropina del 3%, un nivel de confi anza del 95% y una precisióndel 5%, fue de 45 individuos.Resultados: un 15,6% de los pacientes eran hombres, un 20% presentabanbocio, un 24,4% era portador de un hipotiroidismo franco, yen un 73,3% se demostró la presencia de anticuerpos anti-peroxidasaen el suero. No se objetivó una relación estadísticamente signifi cativaentre estas dos últimas características. La prevalencia de anticuerposanti-receptor de tirotropina fue nula para positividad y de un 4,4% paradetectabilidad (2 pacientes).Conclusiones: los pacientes hipotiroideos remitidos a una consulta de Endocrinologíano presentan positividad para anticuerpos anti-receptor detirotropina en suero. Resulta, por tanto, innecesaria la petición de estosanticuerpos en este grupo de pacientes(AU)</dc:description>
<dc:source>Rev Med Univ Navarra;52(4): 15-18, oct.-dic. 2008. tab</dc:source>
<dc:identifier>ibc-62112</dc:identifier>
<dc:title xml:lang="es">Prevalencia de anticuerpos anti-receptor de tirotropina en pacientes con hipotiroidismo autoinmunitario espontáneo</dc:title>
<dc:subject>^d29611</dc:subject>
<dc:subject>^d7217^s22012</dc:subject>
<dc:subject>^d29623</dc:subject>
<dc:subject>^d8657^s22045</dc:subject>
<dc:subject>^d19329^s22073</dc:subject>
<dc:subject>^d7217^s22032</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d1333^s22080</dc:subject>
<dc:subject>^d28596</dc:subject>
<dc:subject>^d1333^s22012</dc:subject>
<dc:subject>^d29203^s22074</dc:subject>
<dc:subject>^d24529^s22038</dc:subject>
<dc:subject>^d28071^s22012</dc:subject>
<dc:subject>^d7217^s22080</dc:subject>
<dc:subject>^d9062</dc:subject>
<dc:subject>^d28071^s22080</dc:subject>
<dc:subject>^d24529^s22021</dc:subject>
<dc:type>article</dc:type>
<dc:date>200812</dc:date>
</metadata>
</record>
</ibecs-document>
